Literature DB >> 33524421

Contradictory regulation of macrophages on atherosclerosis based on polarization, death and autophagy.

Jing Zhang1, Chuan-Rui Ma1, Yun-Qing Hua1, Lan Li1, Jing-Yu Ni1, Yu-Ting Huang1, Sophia Esi Duncan1, Sheng Li1, Shan Gao1, Guan-Wei Fan2.   

Abstract

The main pathological feature of atherosclerosis is lipid metabolism disorder and inflammation. Macrophages, as the most important immune cells in the body, run through the beginning and end of disease development. After macrophages overtake the atherosclerosis-susceptible area apolipoprotein low-density lipoprotein ox-LDL, they transform into foam cells that adhere to blood vessels and recruit a large number of pro-inflammatory factors to initiate the disease. Promoting the outflow of lipids in foam cells and alleviating inflammation have become the basic ideas for the study of atherosclerosis treatment strategies. The polarization of macrophages refers to the estimation of the activation of macrophages at a specific point in space and time. Determining the proportion of different macrophage phenotypes in the plaque can help identify delay or prevent disease development. However, the abnormal polarization of macrophages and the accumulation of lipid also affect the growth state of cells to some extent, thus aggravate the influence on plaque area and stability. Besides, overactive or deficient autophagy of macrophages may also lead to cell death and participate in lipid metabolism and inflammation regression. In this paper, the role of macrophages in atherosclerosis was discussed from three aspects: polarization, death, and autophagy.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Death; Inflammation; Lipid metabolism; Macrophages; Polarization

Mesh:

Year:  2021        PMID: 33524421     DOI: 10.1016/j.lfs.2020.118957

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Effect of autophagy on ferroptosis in foam cells via Nrf2.

Authors:  Qi Peng; Huihui Liu; Zhisheng Luo; Haiyan Zhao; Xinming Wang; Xiuru Guan
Journal:  Mol Cell Biochem       Date:  2022-02-23       Impact factor: 3.396

Review 2.  Programmed cell death in atherosclerosis and vascular calcification.

Authors:  Min Li; Zhen-Wei Wang; Li-Juan Fang; Shou-Quan Cheng; Xin Wang; Nai-Feng Liu
Journal:  Cell Death Dis       Date:  2022-05-18       Impact factor: 9.685

Review 3.  A novel therapeutic strategy for atherosclerosis: autophagy-dependent cholesterol efflux.

Authors:  Haipeng Guo; Dongmei Wei; Rui Liu; Chao Zhang; Song Jiang; Weijia Wang; Hongzhe Hu; Lijuan Shen; Xiaofei Liang
Journal:  J Physiol Biochem       Date:  2022-01-22       Impact factor: 5.080

Review 4.  LKB1 Regulates Vascular Macrophage Functions in Atherosclerosis.

Authors:  Xuewen Wang; Ziwei Liang; Hong Xiang; Yanqiu Li; Shuhua Chen; Hongwei Lu
Journal:  Front Pharmacol       Date:  2021-12-15       Impact factor: 5.810

5.  lnc-MRGPRF-6:1 Promotes M1 Polarization of Macrophage and Inflammatory Response through the TLR4-MyD88-MAPK Pathway.

Authors:  Dan Hu; Yuzhong Wang; Zhihuan You; Yingfei Lu; Caihong Liang
Journal:  Mediators Inflamm       Date:  2022-01-28       Impact factor: 4.711

Review 6.  The Induction of Endothelial Autophagy and Its Role in the Development of Atherosclerosis.

Authors:  Yunqing Hua; Jing Zhang; Qianqian Liu; Jing Su; Yun Zhao; Guobin Zheng; Zhihui Yang; Danping Zhuo; Chuanrui Ma; Guanwei Fan
Journal:  Front Cardiovasc Med       Date:  2022-03-23

Review 7.  A Bibliometric and Knowledge-Map Analysis of Macrophage Polarization in Atherosclerosis From 2001 to 2021.

Authors:  Luxia Song; Jie Zhang; Dan Ma; Yixuan Fan; Runmin Lai; Wende Tian; Zihao Zhang; Jianqing Ju; Hao Xu
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

Review 8.  Liquid-Liquid Phase Separation in Cardiovascular Diseases.

Authors:  Yuanxi Mo; Yuliang Feng; Wei Huang; Ning Tan; Xinyi Li; Minwen Jie; Tong Feng; Hao Jiang; Lei Jiang
Journal:  Cells       Date:  2022-09-28       Impact factor: 7.666

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.